Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stanley C. Erck currently holds 398,328 shares of NOVAVAX INC (NVAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley C. Erck has been a net seller of NVAX stock. They have purchased $742.6K and sold $51.3M worth of shares.
Stanley C. Erck's most recent insider trade was on Aug 13, 2025, when they purchased 100,000 shares at $1.37 per share.
Stanley C. Erck serves as Executive at NOVAVAX INC (NVAX). They have executed 153 insider transactions totaling $52.0M over their tenure at the company.
Stanley C. Erck holds the position of Executive at NOVAVAX INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Stanley C. Erck has shown a selling trading pattern, with $742.6K in total purchases and $51.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stanley C. Erck was on Oct 4, 2021, when they sold $1.6M worth of NVAX shares. This transaction involved 8,890 shares at $177.58 per share.
Stanley C. Erck currently owns 398,328 shares of NOVAVAX INC (NVAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stanley C. Erck's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stanley C. Erck has 153 Form 4 filings on record as an insider at NOVAVAX INC.
Set alerts for Stanley C. Erck and 40,000+ other insiders.